The Fusion Protein MuSK ‐Fc Functions as a Decoy to Block the Binding of Anti‐ MuSK Antibodies to MuSK
Scandinavian Journal of Immunology · 2025
DOI: 10.1111/sji.70033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, 2025. Verfasst von Akiyuki Uzawa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Graduate School of Medicine, Chiba University, Japan. Hauptthemen laut MEDLINE: Myasthenia Gravis, Autoantibodies, Immunoglobulin Fc Fragments, Receptors, Cholinergic. Die Arbeit nennt 16 Literaturangaben. Gefördert von: Ministry of Education, Science and Technology, Ministry of Health, Labour and Welfare.
Abstract (Originalsprache)
Muscle‐specific tyrosine kinase antibody‐positive myasthenia gravis (MuSKMG) is a rare subtype of MG that is often more refractory to immune treatment than acetylcholine receptor (AChR) antibody‐positive MG. Therefore, novel therapeutic strategies are needed. We previously developed AChR‐Fc, an Fc fusion protein that neutralises pathogenic autoantibodies and suppresses pathogenic B cells while preserving normal immunity, as a potential treatment for AChR antibody‐positive MG. Subsequently, we conducted preliminary experiments on MuSK‐Fc, a fusion protein targeting MuSKMG, using patient serum samples. This study examined whether MuSK‐Fc binds to MuSK antibodies and inhibits MuSK antibody binding to MuSK. We found that MuSK‐Fc specifically binds to MuSK antibodies and prevents their interaction with MuSK. These findings indicate that MuSK‐Fc may neutralise pathogenic antibodies and suppress disease activity in MuSKMG.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Graduate School of Medicine, Chiba University, Japan.
- Department of Cardiovascular Medicine, Nephrology, and Neurology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
- Research Institute of Disaster Medicine, Chiba University, Japan.
ORCID-Profile: Akiyuki Uzawa, Manato Yasuda, Satoshi Kuwabara
Förderung
- Ministry of Education, Science and Technology
- Ministry of Health, Labour and Welfare
Zitieren
APA
Uzawa, A., Akamine, H., Yasuda, M., Handa, H., Ogaya, E., Kurumada, K., Onishi, Y., & Kuwabara, S. (2025). The Fusion Protein MuSK ‐Fc Functions as a Decoy to Block the Binding of Anti‐ MuSK Antibodies to MuSK. Scandinavian Journal of Immunology. https://doi.org/10.1111/sji.70033
Vancouver
Uzawa A, Akamine H, Yasuda M, Handa H, Ogaya E, Kurumada K, et al. The Fusion Protein MuSK ‐Fc Functions as a Decoy to Block the Binding of Anti‐ MuSK Antibodies to MuSK. Scandinavian Journal of Immunology. 2025. doi:10.1111/sji.70033
BibTeX
@article{Uzawa2025,
author = {Uzawa, Akiyuki and Akamine, Hiroyuki and Yasuda, Manato and Handa, Hideo and Ogaya, Etsuko and Kurumada, Kentaro and Onishi, Yosuke and Kuwabara, Satoshi},
title = {The Fusion Protein MuSK ‐Fc Functions as a Decoy to Block the Binding of Anti‐ MuSK Antibodies to MuSK},
journal = {Scandinavian Journal of Immunology},
year = {2025},
doi = {10.1111/sji.70033}
}
EUVIMED